Related Experiment Video
Updated: Oct 19, 2025

07:42
Quantification of the Potential Impact of Glyphosate-Based Products on Microbiomes
Published on: January 10, 2022
4.4K
A Glyphosate-Based Formulation but Not Glyphosate Alone Alters Human Placental Integrity
Christelle Simasotchi1, Audrey Chissey1, Gérald Jungers2
1Faculté de Pharmacie, Université de Paris, INSERM, U1139, 3PHM, 4 Avenue de l'Observatoire, F-75006 Paris, France.
Toxics
|September 26, 2021
Summary
Glyphosate formulations, like Roundup, are toxic due to undeclared formulants, not glyphosate alone. These compounds damage placental cells and fetal blood vessels, impacting pregnancy outcomes.
Area of Science:
- Environmental Toxicology
- Reproductive Toxicology
- Cell Biology
Background:
- Glyphosate (G)-based herbicides, notably Roundup (R), are widely used pesticides with potential exposure for pregnant women.
- Formulations contain G as the active ingredient and undeclared 'inert' formulants, which may possess greater toxicity.
Purpose of the Study:
- To compare the toxicity of glyphosate alone versus a glyphosate-based formulation (Roundup) on placental function.
- To investigate the role of formulants in the observed toxicity.
Main Methods:
- Utilized an ex vivo placental perfusion model to assess placental permeability and fetal venous flow.
- Employed immunohistochemistry to evaluate fetal vessel integrity after exposure.
Main Results:
- Roundup, but not glyphosate alone, altered placental permeability and fetal venous flow rate.
- Formulants significantly decreased glyphosate transfer and caused destruction of fetal vessels.
- Evidence suggests formulants, not glyphosate, are the primary toxic agents in the formulation.
Conclusions:
- Undeclared formulants in glyphosate-based herbicides are likely responsible for significant placental and fetal toxicity.
- These findings challenge the focus on glyphosate alone and highlight the need to consider formulation components in pesticide risk assessment.
- The toxicity of formulants may contribute to adverse pregnancy outcomes in exposed mothers.
Related Concept Videos
Teratogenicity
3.1K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.1K
Gonadal and Placental Hormones
2.1K
The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair...
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair...
2.1K
Genomic Imprinting and Inheritance
35.6K
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
35.6K
Mutagenicity and Carcinogenicity
1.5K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.5K

